Martin Anne-Marie
SEC insider (Form 3/4/5 filer). CIK 0001914495. Director at Cullinan Therapeutics, Inc. (CGEM). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 12, 2025. Located in CAMBRIDGE, MA.
Companies Martin Anne-Marie has filed insider reports for
- Cullinan Therapeutics, Inc. (CGEM): Director
Martin Anne-Marie
CIK: 0001914495
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CGEM
Cullinan Therapeutics, Inc.
Director